Edition:
United States

C R Bard Inc (BCR.N)

BCR.N on New York Stock Exchange

322.22USD
21 Jul 2017
Change (% chg)

$0.32 (+0.10%)
Prev Close
$321.90
Open
$321.38
Day's High
$322.85
Day's Low
$321.38
Volume
128,118
Avg. Vol
228,431
52-wk High
$322.85
52-wk Low
$203.63

BCR.N

Chart for BCR.N

About

C. R. Bard, Inc. (Bard) is engaged in designing, manufacturing, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices. The Company operates through the manufacture and sale of medical devices segment. It sells a range of products to hospitals, individual healthcare professionals, extended... (more)

Overall

Beta: 0.60
Market Cap(Mil.): $23,334.26
Shares Outstanding(Mil.): 72.42
Dividend: 0.26
Yield (%): 0.32

Financials

  BCR.N Industry Sector
P/E (TTM): 40.97 32.10 15.85
EPS (TTM): 7.87 -- --
ROI: 15.89 13.54 -8.31
ROE: 37.70 15.90 -7.95

BRIEF-Videocon Telecom launches CCTV brand Wallcam

* Videocon Telecom existing business lines are projected to contribute a topline revenue of 13.58 billion rupees during FY 17-18

Jul 04 2017

BRIEF-BD reports extension of exchange offers and consent solicitations for C. R. Bard notes

* BD announces extension of exchange offers and consent solicitations for C. R. Bard Inc notes

Jul 03 2017

Europe M&A surges but U.S. slows sharply amid uncertainty

Acquisitions of European companies surged in recent months, amid optimism about the region's economic prospects, but global deal-making subsided and the total value of U.S. deals fell sharply due to uncertainty about President Donald Trump's tax reform and deregulation agenda.

Jun 29 2017

Europe M&A surges but U.S. slows sharply amid uncertainty

June 29 Acquisitions of European companies surged in recent months, amid optimism about the region's economic prospects, but global deal-making subsided and the total value of U.S. deals fell sharply due to uncertainty about President Donald Trump's tax reform and deregulation agenda.

Jun 29 2017

BRIEF-BD announces extension of exchange offers, consent solicitations for C. R. Bard notes

* BD announces extension of exchange offers and consent solicitations for C. R. Bard, Inc notes

Jun 05 2017

BRIEF-AngioDynamics lawsuit claims C.R. Bard is violating antitrust laws, harming competition, limiting access

* AngioDynamics - "C.R. Bard has illegally tied sale of tip location systems to line of peripherally inserted central catheters," as per lawsuit filed by co

May 31 2017

BRIEF-Becton Dickinson and Co entered into a three-year term loan agreement

* On May 12, 2017, Becton Dickinson and Company entered into a three-year term loan agreement - SEC filing

May 16 2017

BRIEF-BD announces exercise of option to purchase additional shares by underwriters of public equity offerings

* BD announces exercise of option to purchase additional shares by underwriters of public equity offerings increasing total gross proceeds to $4.95 billion

May 12 2017

BRIEF-Becton Dickinson announces commencement of exchange offers and consent solicitations

* BD announces commencement of exchange offers and consent solicitations for C. R. Bard Inc notes

May 05 2017

Earnings vs. Estimates